Zynerba Pharmaceuticals Inc.

Rank 80
About
Zynerba Pharmaceuticals is a biopharmaceutical company that develops transdermal cannabinoid therapies for the treatment of rare diseases. Conditions include Fragile X syndrome, types of epilepsy, and tourettes. Several products are in the preclinical stages of development. Founded in 2007, Zynerba Pharmaceuticals is based in Pennsylvania, US.
$1.1700
USD
-0.81%
Market cap
$27,141,671
Total volume
$467,563
Shares outstanding
23,198,010
Rank 80
About
Zynerba Pharmaceuticals is a biopharmaceutical company that develops transdermal cannabinoid therapies for the treatment of rare diseases. Conditions include Fragile X syndrome, types of epilepsy, and tourettes. Several products are in the preclinical stages of development. Founded in 2007, Zynerba Pharmaceuticals is based in Pennsylvania, US.
Markets
Exchange | Symbol | Volume (24h) | Volume (%) | Price |
---|---|---|---|---|
|
ZYNE |
$467,563
|
100% |
$1.1700
|
Chart